OR WAIT null SECS
March 02, 2011
Brazil develops its first national plasma fractionation plant.
Q&A with Robert Hardy, chief executive of Aesica
The power of emerging markets is reflected in the pharma's sales and production positions.
INTERPHEX 2011 aims to address the industry's unique characteristics.
The authors outline the key decision points FDA must consider in putting forth a US regulatory pathway for biosimilars.
This article is Part I of a three-part series on biopharmaceutical issues in public health, government, and developing-world markets. Part 1 focuses on drug-development. Part II, which examines manufacturing, appeared in the April 2011 of Sourcing and Management. Part III, which analyzes distribution and administration,appeared in the May 2011 issue.
Contract manufacturers and fine-chemical suppliers announce capacity expansions and service enhancements of Informex.
February 24, 2011
The Society of Chemical Manufacturers and Affiliates (SOCMA), in a statement submitted to the US House Subcommittee on Cybersecurity, Infrastructure Protection and Security Technologies, called for Congressional action to pass a three-to-five year authorization of current Chemical Facility Anti-Terrorism Standards (CFATS), which are scheduled to expire Mar. 4, 2011.
Gilead to Acquire Calistoga; Bayer Healthcare Appoints Former Pfizer Exec; and More.
February 17, 2011
Company and People Notes: sanofi to Acquire Genzyme; Lilly Makes Senior Appointments; and More.